Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
140 participants
INTERVENTIONAL
2016-05-04
2022-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This trial aims to evaluate the need for immediate treatment of local varicosities and the potential sufficiency of main trunk treatment.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Varicose Vein in Patients Under the Age of 40
NCT05410912
Investigation Into the Pathophysiology and Treatment of Varicose Veins
NCT06192472
Mechanochemical Ablation vs Thermal Ablation
NCT03722134
Femoral Nerve Blockade in Endovenous Laser
NCT03475641
Compression And Functional Ability After Endovenous Varicose Vein Treatment
NCT03613376
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Immediate phlebectomy
Mechanochemical ablation of main trunk and immediate phlebectomy of varicosities
Immediate phlebectomy
See arm description
Delayed treatment
Mechanochemical ablation of main trunk. Evaluation of varicosities at 3 months with sclerotherapy if required
Delayed sclerotherapy
See arm descriptions
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Delayed sclerotherapy
See arm descriptions
Immediate phlebectomy
See arm description
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* GSV diameter 5-10 mm
* C2-C4 varicosities
* Most proximal insufficient branch in the distal thigh
* Written and signed informed consent
Exclusion Criteria
* Body mass index \>40
* Lymphoedema
* Known allergy to sclerosant
* Any known coagulopathy or history of deep vein thrombosis
* Severe illness
* Pregnancy
20 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Helsinki University Central Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Maarit Venermo
Professor of Vascular Surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Karoliina Halmesmäki, M.D., Ph.D
Role: PRINCIPAL_INVESTIGATOR
Helsinki University Central Hospital
Maarit Venermo, M.D., Ph.D.
Role: STUDY_DIRECTOR
Helsinki University Central Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Helsinki University Hospital
Helsinki, , Finland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DELICATVE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.